In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection
Abstract Pseudomonas aeruginosa is an opportunistic and frequently drug-resistant pulmonary pathogen especially in cystic fibrosis sufferers. Recently, the frog skin-derived antimicrobial peptide (AMP) Esc(1–21) and its diastereomer Esc(1–21)-1c were found to possess potent in vitro antipseudomonal...
Guardado en:
Autores principales: | Chen Chen, Maria Luisa Mangoni, Y. Peter Di |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/68bccc7475c24d24b7ed3e1ce73fc79e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms
por: Trevor Beaudoin, et al.
Publicado: (2018) -
CD69 mediates the protective role of adipose tissue‐derived mesenchymal stem cells against Pseudomonas aeruginosa pulmonary infection
por: Yanshan Jiang, et al.
Publicado: (2021) -
The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
por: Emma Hennessy, et al.
Publicado: (2014) -
Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
<i>In Vitro</i>
and
<i>In Vivo</i>
por: Dina A. Moustafa, et al.
Publicado: (2021) -
Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes.
por: Adrianne Enos, et al.
Publicado: (2021)